Alonhealth provides a zero‑knowledge proof API that lets insurers, pharma firms, healthcare providers, and researchers verify biometric and health data without exposing raw personal information. The platform aggregates multiple biometric sources into a single secure gateway, delivering cryptographic proofs that satisfy compliance requirements such as GDPR and HIPAA while reducing cyber‑risk.
Funding
Funding not disclosed
Founders
Product
Problem
Healthcare organizations and related industries must verify biometric and personal health data while complying with strict privacy regulations, yet traditional data exchanges expose sensitive information to cyber‑risk and regulatory breaches.
Solution
Alonhealth offers a zero‑knowledge proof (ZKP) based API platform that lets a party confirm the validity of biometric statements without revealing the underlying data. By acting as a secure biometric gateway, the service aggregates multiple biometric data sources—such as wearables, clinical devices, and research datasets—into a single request interface. The ZKP engine cryptographically proves data attributes (e.g., age over a threshold, health condition presence) while keeping raw identifiers hidden, thereby reducing exposure risk and simplifying compliance. The platform delivers the proof to downstream systems, enabling insurers, pharmaceutical firms, and healthcare providers to make risk or eligibility decisions without handling personally identifiable information.
Target Audience
Primary customers include life and health insurers, pharmaceutical companies, healthcare providers, and academic researchers who require secure verification of biometric data.
Features
- Zero‑knowledge proof engine that validates biometric assertions without disclosing raw data
- Unified API endpoint that routes requests to diverse biometric data providers and wearables
- Built‑in compliance support for GDPR, HIPAA, and other data‑protection regulations
- Role‑based access controls and audit logging for secure data governance
- SDKs and documentation for rapid integration into insurance underwriting, drug‑discovery pipelines, and clinical research workflows